Wyethia 119
Commercial- Indications
- Muscle discomfort
Company intelligence / Profile preview
Blesstia Pharmaceutical
Glyfada, Attica, Greece
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Blesstia Pharmaceutical manufactures and supplies GMP/cGMP-approved homeopathic synthesis materials and biopharmaceuticals, positioning itself as one of the few global producers of cGMP-certified raw materials for compounding homeopathics. No clinical trial results are reported in public sources.
- Therapeutic areas
- Other
- Modalities
- Homeopathic synthesisBiopharmaceuticalsGMP/cGMP certified raw materials for compounding homeopathic products
- Industry
- Chemicals & Materials
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Blesstia Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Blesstia Pharmaceutical.